Projects funded by the NCN
Definition of targetable signaling pathways in chronic lymphocytic leukemia patients with rationale to novel therapy with EZH2 inhibition
2018/31/N/NZ5/03344
Keywords:
chronic lymphocytic leukemia personalized medicine targeted therapy next-generation sequencing EZH2 mutation
Descriptors:
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Medyczny w Lublinie, Wydział Lekarski
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 16 - announced on 2018-09-14
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2019-08-12
Project end date (Y-m-d): 2024-08-11
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.